These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6235763

  • 21. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL, Kamo H, Harrop R, Li DK, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB.
    CMAJ; 1986 Mar 15; 134(6):597-607. PubMed ID: 3512063
    [Abstract] [Full Text] [Related]

  • 22. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May 15; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 23. Positron emission tomography in Alzheimer's disease.
    Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI.
    Neurology; 1986 Jul 15; 36(7):879-87. PubMed ID: 3487046
    [Abstract] [Full Text] [Related]

  • 24. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A, Newberg AB, Souder E, Berlin JA.
    J Nucl Med; 1993 Oct 15; 34(10):1681-7. PubMed ID: 8410281
    [Abstract] [Full Text] [Related]

  • 25. Cerebral metabolic pattern in young adult Down's syndrome subjects: altered intercorrelations between regional rates of glucose utilization.
    Horwitz B, Schapiro MB, Grady CL, Rapoport SI.
    J Ment Defic Res; 1990 Jun 15; 34 ( Pt 3)():237-52. PubMed ID: 2143230
    [Abstract] [Full Text] [Related]

  • 26. P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.
    Szelies B, Mielke R, Grond M, Heiss WD.
    J Neurol Sci; 1995 May 15; 130(1):77-81. PubMed ID: 7650534
    [Abstract] [Full Text] [Related]

  • 27. Age differences in intercorrelations between regional cerebral metabolic rates for glucose.
    Horwitz B, Duara R, Rapoport SI.
    Ann Neurol; 1986 Jan 15; 19(1):60-7. PubMed ID: 3484930
    [Abstract] [Full Text] [Related]

  • 28. Positron emission tomography in normal aging and Alzheimer's disease.
    Rapoport SI.
    Gerontology; 1986 Jan 15; 32 Suppl 1():6-13. PubMed ID: 3488245
    [Abstract] [Full Text] [Related]

  • 29. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T, Ferris SH, Wolf AP, De Leon MJ, Christman DR, Reisberg B, Alavi A, Fowler JS, George AE, Reivich M.
    Am J Psychiatry; 1982 Mar 15; 139(3):352-3. PubMed ID: 6977276
    [No Abstract] [Full Text] [Related]

  • 30. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ, Alexander GE, Schapiro MB, Möller HJ, Rapoport SI, Hampel H.
    Brain; 2004 Apr 15; 127(Pt 4):811-24. PubMed ID: 14985261
    [Abstract] [Full Text] [Related]

  • 31. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
    Alexander GE, Furey ML, Grady CL, Pietrini P, Brady DR, Mentis MJ, Schapiro MB.
    Am J Psychiatry; 1997 Feb 15; 154(2):165-72. PubMed ID: 9016263
    [Abstract] [Full Text] [Related]

  • 32. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.
    Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE.
    J Comput Assist Tomogr; 1983 Aug 15; 7(4):590-8. PubMed ID: 6602819
    [Abstract] [Full Text] [Related]

  • 33. EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease.
    Valladares-Neto DC, Buchsbaum MS, Evans WJ, Nguyen D, Nguyen P, Siegel BV, Stanley J, Starr A, Guich S, Rice D.
    Neuropsychobiology; 1995 Aug 15; 31(4):173-81. PubMed ID: 7659198
    [Abstract] [Full Text] [Related]

  • 34. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE.
    J Nucl Med; 1997 May 15; 38(5):797-802. PubMed ID: 9170449
    [Abstract] [Full Text] [Related]

  • 35. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM, Hedley-Whyte ET.
    J Neuropathol Exp Neurol; 1990 Sep 15; 49(5):509-20. PubMed ID: 2148772
    [Abstract] [Full Text] [Related]

  • 36. Positron emission tomography in aging and dementia: effect of cerebral atrophy.
    Chawluk JB, Alavi A, Dann R, Hurtig HI, Bais S, Kushner MJ, Zimmerman RA, Reivich M.
    J Nucl Med; 1987 Apr 15; 28(4):431-7. PubMed ID: 3494824
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.
    Foster NL, VanDerSpek AF, Aldrich MS, Berent S, Hichwa RH, Sackellares JC, Gilman S, Agranoff BW.
    J Cereb Blood Flow Metab; 1987 Aug 15; 7(4):415-20. PubMed ID: 3497161
    [Abstract] [Full Text] [Related]

  • 40. Gender differences in cortical glucose metabolism in Alzheimer's disease and normal aging.
    Siegel BV, Shihabuddin L, Buchsbaum MS, Starr A, Haier RJ, Valladares Neto DC.
    J Neuropsychiatry Clin Neurosci; 1996 Aug 15; 8(2):211-4. PubMed ID: 9081560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.